Profile
VOR VRTX REGN VRNA ARGX ALNY
Company Name Vor Biopharma Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $56.06M $116.06B $76.56B $72.68B $53.66B $52.51B
Employees 0.16K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Jean-Paul Kress Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
VOR VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
VOR VRTX REGN VRNA ARGX ALNY
Last Close $10.02 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $48.72 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.15 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -79.43 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 6580 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
VOR VRTX REGN VRNA ARGX ALNY
1 Month Return -65.45 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 391.18 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 5564.22 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 600.7 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 802.7 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 1209.46 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
VOR VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.47 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -205.97 % 9.76 % 4.25 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 6.06 % - - -
Growth
VOR VRTX REGN VRNA ARGX ALNY
Asset Growth -31.9 % 14.15 % 53.91 %
Gross Profit Growth 100 % 12.5 % -
Revenue Growth - 8.27 % -
Revenue 3 Year - -13.44 % -15.89 %
Revenue 5 Year - 119.18 % -
Revenue 10 Year - 429.43 % -
EBIT Growth -2.82 % 13.17 % -131.37 %
Net Income Growth 0.81 % 11.61 % -224.78 %
Net Income 3 Yeari Growth Per Share 8.19 % -46.47 % -148.34 %
Net Income 5 Yeari Growth Per Share -451.81 % 111.07 % 25.82 %
Net Income 10 Yeari Growth Per Share -131.99 % 1232.49 % -35.51 %
Operating Income Growth 3.85 % -8.23 % -133.02 %
Operating Cash Flow Growth (CFG) 0.63 % -3.78 % -143.33 %
Operating 3 Year CFG 22.01 % -38.85 % -170.73 %
Operating 5 Year CFG -446.36 % 84.11 % 54.81 %
Operating 10 Year CFG -208.56 % 517.51 % 40.15 %
EPS Growth 2.86 % 10.39 % -214.81 %
EPS Diluted Growth 2.86 % 10.27 % -208.93 %
Book Value Per Share -37.28 % 11.76 % -22.82 %
Share Holder 3 Year Equity Growth Per Share -75.82 % 53.21 % 1.82 %
Share Holder 5 Year Equity Growth Per Share 583.58 % 167.88 % -24.45 %
Share Holder 10 Year Equity Growth Per Share 217.69 % 1113.59 % -71.86 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -10.74 % 0.06 % 139.05 %
Free Cash Flow Growth 1.45 % -0.08 % -144.48 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
VOR VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 50 % 86.28 % 85.39 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -1389.92 % 14.78 % 11.4 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM 274.58 % 19.62 % 15.31 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -233.16 % 19.59 % 10.32 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 88.98 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 667.47 % 111.4 % 139.5 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -9956.4 % 34.06 % 25.89 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -4706.6 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.51 1.93 1.91 3.33
Payables Turnover TTM - 0.4 2.3 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.64 0.94 2.26 6.82
Fixed Asset Turnover TTM 111.23 % 388.59 % 284.82 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 2.09 % 47.15 % 35.47 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -21.55 14.55 48.94 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -21.65 13.06 40.09 -0.85 5.58 1.68
Cash Per Share TTM 2551.14 % 2459.7 % 8148.65 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -3906 % 31.71 % 35.59 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.49 % 89.76 % 81.92 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -4706.6 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.39 34.78 18.43 -995.27 126.92 237.2
Price To Operating Cash Flows Ratio TTM -0.38 31.09 15.15 -126.33 144.96 196.51
Price Cash Flow Ratio TTM -0.38 31.09 15.15 -126.33 144.96 196.51
Income Statement (TTM)
VOR VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.2B $0.03B $2.19B $2.25B
Gross Profit $0B $9.49B $12.23B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 86.13% 93.89% 89.62% 85.62%
EBITDA $-0.12B $0.49B $5.32B $-0.12B $0.11B $-0.18B
Net Income $-0.12B $-0.54B $4.41B $-0.14B $0.83B $-0.28B
EPS Diluted -34 -2.08 38.34 -1.73 12.78 -2.18
Balance Sheet (MRQ)
VOR VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.03B $1.66B $2.7B $0.12B $0.03B $2.59B
Total Liabilities $0.05B $6.12B $8.41B $0.27B $0.7B $4.17B
Total Equity $0.1B $16.41B $29.35B $0.2B $5.5B $0.07B
Total Investments $0.01B $6.65B $15.42B $0.02B $1.93B $1.73B
Total Debt $0.03B $1.75B $2.7B $0.12B $0.04B $2.74B
Total Assets $0.14B $22.53B $37.76B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
VOR VRTX REGN VRNA ARGX ALNY
Net Income $-0.12B $-0.54B $4.41B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.1B $-0.49B $4.42B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.76B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 29.437
AARD Aardvark Therapeutics, Inc. Common Stock 13.92
ABCL AbCellera Biologics Inc. 3.46
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.1
ABPWW 0.02
ABSI Absci Corporation 3.55
ABUS Arbutus Biopharma Corporation 4.59
ABVC ABVC BioPharma, Inc. 2.06
ABVX Abivax SA American Depositary Shares 110.98
ACAD ACADIA Pharmaceuticals Inc. 26.8
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.465
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.38
ACIU AC Immune SA 3.29
ETFs With Exposure to VOR
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00156 249.9
VTI Vanguard Total Stock Market Index Fund 0.00019 334.36
IBB iShares Biotechnology ETF 0.01 168.11
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00015 147.82
IWN iShares Russell 2000 Value ETF 0.00393 184.41
BIB ProShares Ultra Nasdaq Biotechnology 0.01 79.3179
VXF Vanguard Extended Market Index Fund 0.00024 211.15
HDG ProShares Hedge Replication ETF 0.000314694 51.64
UWM ProShares Ultra Russell2000 0.000630567 48.75
VTHR Vanguard Russell 3000 Index Fund 0 299.61
IWC iShares Micro-Cap ETF 0.00626 160.81
URTY ProShares UltraPro Russell2000 0.000299367 56.12
VTWV Vanguard Russell 2000 Value Index Fund 0 163.567
VTWO Vanguard Russell 2000 Index Fund 0 101.37
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00019 113.75
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0.00019 113.73
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00012 53.23
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00012 53.22
VBINX Vanguard Balanced Index Fund Investor Shares 0.00012 53.22
RYLD Global X Russell 2000 Covered Call ETF 0 15.385
BMED BlackRock Future Health ETF 0.06313 30.15
DFAU Dimensional US Core Equity Market ETF 0.00007328 46.57
IBBQ Invesco Nasdaq Biotechnology ETF 0.03 28.36
DFAT Dimensional U.S. Targeted Value ETF 0.00001351 60.27
DFAC Dimensional U.S. Core Equity 2 ETF 0.0000803 39.43
VTSAX Vanguard Total Stock Market Index Fund 0.00019 162.79
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02 8.245
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00024 160.26
VITSX Vanguard Total Stock Market Index Fund 0.00019 162.82
DFSU Dimensional US Sustainability Core 1 ETF 0.00056126 43.34
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000102858 16.3
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00024 160.27
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.00196238 40.39
VWSTX Vanguard Short-Term Tax-Exempt Fund 0.11602 15.87
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
AVSC Avantis U.S. Small Cap Equity ETF 0 59.77
VTS.AX Vanguard US Total Market Shares Index ETF 0.00019 504.82
DCOR Dimensional ETF Trust 0.00025868 73.32
VEMPX Vanguard Extended Market Index InstlPlus 0.00024 395.49
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00019 305.43
RSSL Global X Funds 0 98.445
RFLR Innovator ETFs Trust 0 28.87
Unlock